Recorded talks from conferences across Europe, Latin America, and North America where our founders have shared findings and personal data with scientific and public audiences.
Transvision 2025
Kenneth Scott takes the stage at TransVision Madrid 2025 to present on clinical longevity practices across Spain, Latin America, and beyond — bringing an investor's lens and decades of personal data to one of Europe's leading longevity summits.
RAADFEST 2024 Foundation Presentation
At 81, Kenneth Scott has tested his biological age at 18 — a 62-year difference. Longevity Live spoke with KHL Foundation's co-founder about the therapies, mindset, and decades of discipline behind that number.
People Unlimited conference Foundation Appearance
Kenneth Scott takes the stage at the People Unlimited conference to walk the audience through a thought experiment — and make the case that getting back the body, mind, and energy of your 20s is not a fantasy, but the only target worth aiming for.
RAADFEST 2023 Foundation Participation
Kenneth Scott takes the stage at TransVision Madrid 2025 to present on clinical longevity practices across Spain, Latin America, and beyond — bringing an investor's lens and decades of personal data to one of Europe's leading longevity summits.
Clinical & Rejuvenation Work
At 81, Kenneth Scott has tested his biological age at 18 — a 62-year difference. Longevity Live spoke with KHL Foundation's co-founder about the therapies, mindset, and decades of discipline behind that number.
Exosome Research: Foundation clinical Study
Kenneth Scott breaks down exactly how amniotic exosome therapy works, what it did for his wife's tendon damage from a fluoroquinolone antibiotic, and why the FDA will never approve it — even though doctors can legally administer it today.
Biological Alignment-Foundation Overview
In this two-hour conversation with longevity researcher Dr. Michael Lustgarten, Kenneth Scott walks through his complete protocol at 82 — diet, Khavinson peptides, follistatin gene therapy, VSEL stem cells, senolytics, and the biotech investments he believes will make true rejuvenation possible in his lifetime.
